Patent details

Basic Information

Publication number:

EP2968235

PCT Application Number:

US2014020958

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147172464

PCT Publication Number:

WO2014149789

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF CANAGLIFLOZIN AND PROBENECID FOR THE TREATMENT OF HYPERURICEMIA

French Title of Invention:

COMBINAISON DE CANAGLIFLOZINE ET PROBÉNÉCIDE POUR LE TRAITEMENT DE L'HYPERURICÉMIE

German Title of Invention:

KOMBINATION AUS CANAGLIFLOZIN UND PROBENECID ZUR BEHANDLUNG VON HYPERURIKÄMIE

SPC Number:

Dates

Filing date:

06/03/2014

Grant date:

13/09/2017

EP Publication Date:

20/01/2016

PCT Publication Date:

25/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/09/2017

EP B1 Publication Date:

13/09/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/03/2018

Expiration date:

06/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/09/2017

 

 

Name:

Janssen Pharmaceutica NV

Address:

Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Inventor

1

Name:

ROTHENBERG, Paul

Address:

United States (US)

2

Name:

WAYS, Douglas., K

Address:

United States (US)

Priority

Priority Number:

201361786738 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/19; A61K 31/7042; A61P 19/06;

Publication

European Patent Bulletin

Issue number:

201737

Publication date:

13/09/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1